AVAH holder files to sell 489,500 shares

AVAH filed a Rule 144 notice covering the planned sale of 489,500 shares of common stock, with an aggregate market value of $3,881,735.00, through Morgan Stanley Smith Barney on the NASDAQ around 02/19/2026.

Accepted by SEC EDGAR 02/17/2026 - 08:34 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

AVAH filed a Rule 144 notice covering the planned sale of 489,500 shares of common stock, with an aggregate market value of $3,881,735.00, through Morgan Stanley Smith Barney on the NASDAQ around 02/19/2026.

The shares to be sold relate to a larger block of 978,851 common shares acquired from the issuer via restricted stock vesting on 02/14/2026. In the prior three months, the same account sold 84,960 shares of common stock on 01/02/2026 for gross proceeds of $689,985.65.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AVAH Form 144 filing disclose?

The Form 144 discloses a planned Rule 144 sale of 489,500 AVAH common shares with an aggregate market value of $3,881,735.00, to be executed through Morgan Stanley Smith Barney on the NASDAQ around February 19, 2026.

How many AVAH shares are planned to be sold under this Form 144?

The filing covers a proposed sale of 489,500 AVAH common shares. These shares are listed with an aggregate market value of $3,881,735.00 and are expected to be sold on the NASDAQ through Morgan Stanley Smith Barney around February 19, 2026.

When were the AVAH shares in this Form 144 acquired and how?

The shares relate to 978,851 AVAH common shares acquired on February 14, 2026 via a restricted stock vesting transaction from the issuer. The Form 144 ties the planned sale to this vesting event, with payment also dated February 14, 2026.

What prior AVAH share sales are reported in the last three months?

The filing reports that 84,960 AVAH common shares were sold on January 2, 2026, generating gross proceeds of $689,985.65. The seller listed is Morgan Stanley Smith Barney Executive Financial Services at its New York address.

On which exchange will the AVAH shares in this Form 144 be sold?

The planned Rule 144 sale of 489,500 AVAH common shares is designated for the NASDAQ. The filing lists Morgan Stanley Smith Barney Executive Financial Services as the broker handling the transaction on this exchange on or about February 19, 2026.

What is the market value of the AVAH shares covered by the Form 144?

The proposed sale of 489,500 AVAH common shares has an aggregate market value of $3,881,735.00. This figure is based on pricing at the time of the notice and is disclosed alongside the intended NASDAQ sale date of February 19, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001520693
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aveanna Healthcare Holdings, Inc.
SEC File Number	001-40362
Address of Issuer	400 INTERSTATE NORTH PARKWAY STE 1700 ATLANTA GEORGIA 30339
Phone	770-441-1580
Name of Person for Whose Account the Securities are To Be Sold	Shaner Jeff
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	489500	3881735.00	2394179	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/14/2026	Restricted Stock Vesting	Issuer			978851	02/14/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	Common Stock	01/02/2026	84960	689985.65

144: Remarks and Signature

Remarks	These shares will automatically be sold on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on the date of the vesting event. The sale is mandated by the Reporting Person's adoption of a Rule 10b5-1 trading plan and does not represent a discretionary trade by the Reporting Person.
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jonathan Beckler
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)